Clean Science Revenue Climbs 8% on Record HALS Volumes

CHEMICALS
Whalesbook Corporate News Logo
AuthorKavya Nair|Published at:
Clean Science Revenue Climbs 8% on Record HALS Volumes
Overview

Clean Science reported an 8% sequential revenue increase in Q4 FY26, reaching INR 246 crores. This growth was driven by higher volumes, particularly in its Hindered Amine Light Stabilizers (HALS) business, which achieved record quarterly revenue. Additionally, its subsidiary, Clean Fino-Chem Limited, reported its first quarter of positive EBITDA.

Instant Stock Alerts on WhatsApp

Used by 10,000+ active investors

1

Add Stocks

Select the stocks you want to track in real time.

2

Get Alerts on WhatsApp

Receive instant updates directly to WhatsApp.

  • Quarterly Results
  • Concall Announcements
  • New Orders & Big Deals
  • Capex Announcements
  • Bulk Deals
  • And much more

Clean Science Reports Strong Sequential Revenue Growth in Q4 FY26

Clean Science and Technology Limited announced a sequential revenue increase of 8% for its standalone business, totaling INR 193 crores. The consolidated business saw a 14% rise, reaching INR 246 crores in the fourth quarter of fiscal year 2026. These gains were primarily driven by increased sales volumes.

Key Developments

During its Q4 FY26 earnings call on May 14, 2026, Clean Science highlighted significant sequential improvements. The company's Hindered Amine Light Stabilizers (HALS) business achieved its highest-ever quarterly revenue. HALS volumes more than tripled over the past eight quarters, exceeding 1,000 tonnes. Furthermore, its subsidiary, Clean Fino-Chem Limited, achieved its first quarter of positive EBITDA, posting INR 7 crores. In a move to align with stakeholders, promoter directors voluntarily reduced their performance bonus entitlement, resulting in an INR 11 crore reversal.

Significance of the Results

The sequential revenue growth, bolstered by higher volumes in the valuable HALS segment, suggests a potential turnaround for the company. The subsidiary's positive EBITDA marks a crucial step towards profitability for that unit. The promoter's bonus reduction, though a one-time benefit, demonstrates a commitment to stakeholder interests during a challenging period.

Background

Clean Science has been actively working to expand its HALS capacity and market presence. The company has also focused on optimizing its newer facilities, including the Hydroquinone (HQ) and Catechol plant, which had low initial utilization. Previously, the company experienced a year-on-year revenue decline due to pricing pressures and the loss of a significant FMCG account.

Future Outlook and Targets

The company anticipates the new Performance Chemical 2 facility will be commercialized by September 2026. The Hydroquinone plant is expected to reach optimal efficiency within the next one to two quarters. Clean Science is targeting a blended realization of $7.00 to $7.50 per kg for HALS.

Potential Risks

Management noted uncertainty in projecting FY27 performance due to reliance on crude oil prices and global geopolitical factors. Significant increases in commodity prices for Acetone and Ammonia present a risk to the HALS business. Ongoing pricing pressure, compounded by long-term contracts that limit immediate cost pass-through, remains a concern.

Contextual Performance Metrics

  • HALS volumes increased from approximately 350 tonnes per quarter eight quarters ago to over 1,000 tonnes in Q4 FY26.
  • Clean Fino-Chem reported INR 7 crores EBITDA in Q4 FY26.
  • The Performance segment accounted for 72% of the full-year revenue.
  • Blended HALS realization improved to INR 460 per kg from INR 420-430 per kg previously.

Key Areas for Investors

Investors will closely watch the ramp-up in Hydroquinone plant utilization and the timely launch of the Performance Chemical 2 facility. The company's success in achieving its target HALS realization and managing input cost volatility will be critical.

Get stock alerts instantly on WhatsApp

Quarterly results, bulk deals, concall updates and major announcements delivered in real time.

Disclaimer:This content is for educational and informational purposes only and does not constitute investment, financial, or trading advice, nor a recommendation to buy or sell any securities. Readers should consult a SEBI-registered advisor before making investment decisions, as markets involve risk and past performance does not guarantee future results. The publisher and authors accept no liability for any losses. Some content may be AI-generated and may contain errors; accuracy and completeness are not guaranteed. Views expressed do not reflect the publication’s editorial stance.